Hengdong Shengwu

Zhongshan, China · Founded 2021 · Privately Held (backing)

Developer of agonist antibody drugs intended for tumour targeting. Hengdong Shengwu is based in Zhongshan, China and was founded in 2021.

Last price · $/share
—
Implied valuation
—
Total raised
—
Last round
—
Funding — no rounds on record

No funding rounds for Hengdong Shengwu are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Hengdong Shengwu with a free account
  • ·Watch Hengdong Shengwu: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Hengdong Shengwu investors

3 investors are on record for Hengdong Shengwu, including Tengye Ventures, Zhongshan Health Base Group and Zhongshan Torch Electronic Industry Fund Management.

For fundraisers
Raising for a company like Hengdong Shengwu?

3 investors have backed Hengdong Shengwu.

See all 3 investors →